Document is current
Any future updates will be listed below
-
Authors
Moore, Catherine F.
Bedillion, Margaret F.
Haney, Margaret
Weerts, Elise M.
- License Information
-
More Information
Article History
Received: 20 May 2025
Accepted: 8 December 2025
First Online: 29 December 2025
Declarations
:
: CM and EW received funds from MyMD Pharmaceuticals Inc. and MIRA Pharmaceuticals Inc. for contract preclinical research unrelated to the present review. EW received funds from Cultivate Biologics LLC and Canopy Growth Corp. for clinical projects unrelated to the present review. MH has been a consultant for Anebulo Pharmaceuticals, is a stockholder of and on the scientific advisory board for PleoPharma, and has received cannabis capsules from Tilray for research on neuropathic pain. MB has no conflicts of interest to declare.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
